4//SEC Filing
Adams Kendra 4
Accession 0001662579-23-000097
CIK 0001662579other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 7:21 PM ET
Size
7.2 KB
Accession
0001662579-23-000097
Insider Transaction Report
Form 4
Adams Kendra
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-09-18+111,000→ 111,000 totalExercise: $2.15Exp: 2033-09-17→ Common Stock (111,000 underlying) - Award
Common Stock
2023-09-18+25,000→ 46,640 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on September 18, 2024, subject to the Reporting Person's continued service on each vesting date.
- [F2]25% of this option shall vest and become exercisable on September 18, 2024, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service on each vesting date.
Documents
Issuer
C4 Therapeutics, Inc.
CIK 0001662579
Entity typeother
Related Parties
1- filerCIK 0001991929
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 7:21 PM ET
- Size
- 7.2 KB